$SVMB
Jingbo Technology, Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315222028512 Filed on October 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue
YoY Change
Cost Of Revenue $2.085M
YoY Change
Gross Profit -$596.7K
YoY Change
Gross Profit Margin
Selling, General & Admin $24.72K $13.93K $19.94K
YoY Change 327.66% -30.14%
% of Gross Profit
Research & Development $267.8K $6.521K
YoY Change
% of Gross Profit
Depreciation & Amortization $276.4K $327.9K
YoY Change
% of Gross Profit
Operating Expenses $24.72K $13.93K $19.94K
YoY Change 327.66% -30.16%
Operating Profit -$621.4K -$13.93K -$19.94K
YoY Change -30.16%
Interest Expense $160.00 $100.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$77.34K -$63.54K
YoY Change
Pretax Income -$24.72K -$13.93K -$19.94K
YoY Change 327.66% -30.14%
Income Tax
% Of Pretax Income
Net Earnings -$24.72K -$13.93K -$19.94K
YoY Change 327.66% -30.16%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share -$0.06 -$225.00 -$322.10
COMMON SHARES
Basic Shares Outstanding 61.90M shares 61.90M shares 61.90M shares
Diluted Shares Outstanding 61.90M shares 61.90M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $610.00
YoY Change -100.0% -100.0%
Cash & Equivalents $610.00
Short-Term Investments
Other Short-Term Assets $0.00 $10.00
YoY Change -100.0%
Inventory
Prepaid Expenses $10.00
Receivables
Other Receivables
Total Short-Term Assets $10.00 $610.00
YoY Change -98.36%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.00 $610.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $10.00 $610.00
YoY Change -98.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $3.830K $18.88K
YoY Change -100.0% -79.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $46.61K $21.90K $62.03K
YoY Change -31.27% -64.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $46.61K $21.90K $62.03K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $46.61K $21.90K $62.03K
YoY Change -31.27% -64.69%
SHAREHOLDERS EQUITY
Retained Earnings -$299.2K -$274.5K
YoY Change
Common Stock $252.6K $252.6K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$46.61K -$21.89K -$61.42K
YoY Change
Total Liabilities & Shareholders Equity $10.00 $610.00
YoY Change -98.36%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$24.72K -$13.93K -$19.94K
YoY Change 327.66% -30.16%
Depreciation, Depletion And Amortization $276.4K $327.9K
YoY Change
Cash From Operating Activities -$28.54K -$18.07K -$13.05K
YoY Change 24.68% 38.49%
INVESTING ACTIVITIES
Capital Expenditures $346.8K $716.1K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $41.40K $33.20K
YoY Change
Cash From Investing Activities -$305.3K -$682.9K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.54K $18.07K 12.85K
YoY Change 25.84% 40.65%
NET CHANGE
Cash From Operating Activities -28.54K -$18.07K -13.05K
Cash From Investing Activities -305.3K -$682.9K
Cash From Financing Activities 28.54K $18.07K 12.85K
Net Change In Cash 0.000 -200.0
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$28.54K -$18.07K -$13.05K
Capital Expenditures $346.8K $716.1K
Free Cash Flow -$375.3K -$734.2K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Gross Profit
GrossProfit
usd
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001647822
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
333-206804
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
Savmobi Technology, Inc.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3240707
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
Building B8
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
China Zhigu
CY2022Q3 dei Entity Address Address Line3
EntityAddressAddressLine3
Yinhu Street, Fuyang District
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Hangzhou, Zhejiang
CY2022Q3 dei Entity Address Country
EntityAddressCountry
CN
CY2022Q3 dei City Area Code
CityAreaCode
86
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
57187197085
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61900000 shares
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
10 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
35 usd
CY2022Q3 us-gaap Assets
Assets
10 usd
CY2022Q2 us-gaap Assets
Assets
35 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3829 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8000 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
18073 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
21902 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8001 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61900000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61900000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61900000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61900000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
61900 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
61900 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
190734 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
190734 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-274526 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-260600 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-21892 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-7966 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13926 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19938 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
13926 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
19938 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13926 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-19938 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61900000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61900000 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-41477 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-19938 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-61415 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-7966 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13926 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-21892 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13926 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-19938 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-25 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4171 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6884 usd
CY2022Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18073 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13054 usd
CY2022Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
18073 usd
CY2021Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
12850 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18073 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12850 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-204 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
815 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
611 usd
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z00GgOtAuMP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zC03CnScaWf4">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. The management makes its best estimate of the outcome for these items based on information available when the financial statements are prepared, however, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61900000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61900000 shares
CY2022Q3 SVMB Working Capital Deficit
WorkingCapitalDeficit
21892 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18073 usd
CY2022Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
10 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3829 usd
CY2022Q3 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Tax Act reduces the U.S. statutory corporate tax rate from 35% to 21% for our tax years beginning in 2018, which resulted in the re-measurement of the federal portion of our deferred tax assets from the 35% to 21% tax rate
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
142032 usd
CY2022Q3 SVMB Operating Loss Carryforwards Expiration Description
OperatingLossCarryforwardsExpirationDescription
expire in 2042
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29827 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29827 usd

Files In Submission

Name View Source Status
0001493152-22-028512-index-headers.html Edgar Link pending
0001493152-22-028512-index.html Edgar Link pending
0001493152-22-028512.txt Edgar Link pending
0001493152-22-028512-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
svmb-20220831.xsd Edgar Link pending
svmb-20220831_cal.xml Edgar Link unprocessable
svmb-20220831_pre.xml Edgar Link unprocessable
svmb-20220831_def.xml Edgar Link unprocessable
svmb-20220831_lab.xml Edgar Link unprocessable